4th LNP Formulation & Process Development
The 4th LNP Formulation & Process Development Summit (April 14-16, 2025 | Boston, MA) is the largest forum dedicated to the end-to-end LNP Development, this summit brings together 230+ discovery, formulation, analytics, delivery and CMC experts. It’s an unrivalled opportunity to delve into the latest scientific content to advance LNP development for different payloads and therapeutic applications.
View the brand-new event guide.
For the very first time, Pieter Cullis, Professor at University of British Columbia will be speaking at the summit along with 50+ LNP industry leaders including:
- Annette Bak, Head, Advanced Drug Delivery, AstraZeneca
- Sanyogitta Puri, Senior Director, Non-Viral Delivery, Novo Nordisk
- Muthiah (Mano) Manoharan, Senior Vice President, Innovation Chemistry & Alnylam Distinguished Scientist, Alnylam Pharmaceuticals
- George Dakwar, Director, Formulation Platform, CureVac
- Saswata Karmakar, Director, Chemistry, Sanofi
- Alexey Popov, Vice President, Head, Process Development, Sail Biomedicines
- Sudhakar Garad, Global Head, Pre-Formulation, Novel Delivery & Biopharmaceutics, Novartis
- Peng Zhang, Principal Scientist, US Pharmacopeia
View the world-class speaker faculty.
Across 3 days and 3 tracks of content, gain actionable insights to achieve deeper LNP characterization with cryo-EM, improve extrahepatic delivery with novel ionizable lipids and delve into optimal large-scale manufacturing strategies to fast-track safe, compliant and scalable LNPs towards the clinic.
Download the agenda to discover the sessions revolutionizing LNP development.
